TX Houston의 위장관 암 임상 시험
위장관 암 관련 연구 21개가 Houston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
피험자 모집 중3상
- Oncology Consultants P.A., Houston
- Oncology Consultants P.A., Houston
- Texas Oncology - Gulf Coast, Houston
- 외 7개
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
피험자 모집 중3상
- GSK Investigational Site, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
피험자 모집 중1/2상
- MD Anderson, Houston
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
피험자 모집 중1/2상
- Baylor College of Medicine, Houston
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
피험자 모집 중2상
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- The University of Texas, MD Anderson Cancer Center, Houston
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
피험자 모집 중1/2상
- GSK Investigational Site, Houston
Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers
피험자 모집 중관찰 연구
- M D Anderson Cancer Center, Houston
Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
피험자 모집 중
- MD Anderson Cancer Center, Houston
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
피험자 모집 중1상
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
Telephone Support in Advanced Gastrointestinal Cancer
피험자 모집 중
- MD Anderson Cancer Center, Houston
Improving Comprehensive Care of Cancer Patients
피험자 모집 중건강한 지원자 환영
- Baylor College of Medicine, Houston
BOLSTER: Learning New Skills to Thrive
피험자 모집 중
- The University of Texas MD Anderson Cancer Center, Houston
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
피험자 모집 중관찰 연구
- M D Anderson Cancer Center, Houston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- University of Texas, MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
피험자 모집 중1/2상
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
Molecular Epidemiology of Biliary Tree Cancers
피험자 모집 중관찰 연구
- M D Anderson Cancer Center, Houston
Traction vs. No Traction in Colonic ESD
피험자 모집 중
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
피험자 모집 중
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
다른 도시의 위장관 암 시험
- Boston, MA연구 15개
- New York City, NY연구 12개
- Nashville, TN연구 10개
- Los Angeles, CA연구 9개
- Dallas, TX연구 8개
- Durham, NC연구 8개
- Baltimore, MD연구 8개
- Arlington, VA연구 8개
- Cincinnati, OH연구 8개
- San Antonio, TX연구 7개
- Seattle, WA연구 7개
- Aurora, CO연구 7개
Houston의 다른 연구
- 비소세포폐암연구 145개
- 유방암연구 126개
- 암 (전체)연구 122개
- 전이성 암연구 104개
- 대장직장암연구 103개
- 난소암연구 90개
- 급성 골수성 백혈병연구 86개
- 폐암연구 78개
- 전립선암연구 76개
- 자궁내막암연구 69개
- 췌장암연구 62개
- 흑색종연구 59개
ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.